Abstract
MicroRNA-146a acts as a critical physiological brake role to prevent the overactivation of inflammatory response pathways and was a key negative regulator of autoimmunity. Ets-1 could bind to the MicroRNA-146a promoter region as a regulator of MicroRNA-146a expression in vitro. IRAK1 is a prominent target of MicroRNA-146a that help it to negatively regulate the release of IL8. This study aimed to investigate the association of MicroRNA-146a, Ets-1(negative regulator) and IRAK1(target) polymorphisms with Psoriasis Vulgaris(PsV), the most prevalent chronic inflammatory skin disease in adults, in a Southern Chinese cohort. Seven SNPs in microRNA-146a (rs2431697; rs2910164; rs57095329), Ets-1(rs10893872; rs1128334) and IRAK1(rs1059703; rs3027898) genes were genotyped in 673 subjects (360 PsV cases and 313 controls) by SNaPshot Multiplex Kit (Applied Biosystems Co., USA). We found significant difference in the genotype and allele frequencies of rs2431697 and rs2910164 in MicroRNA-146a gene between the PsV cases and the controls. The dominant model genotype (CC+CT) (p=0.019; OR=1.463) and allele (C) (p=0.027; OR=1.496) of rs2431697 and the GG genotype (p= 0.027; OR=1.582) and allele (G) of rs2910164 were associated with an increased risk of PsV. There was no association of the SNPs with the clinical traits of PsV. Our data provide preliminary evidence that the rs2431697 and rs2910164 polymorphism in the microRNA-146a gene may be involved in the genetic susceptibility to PsV in Southern Chinese. Although further function studies will be required to identify the details of the process, the findings could make a significant step forward in our understanding of the genetic contribution to psoriasis.
What’s already known about this topic?
MicroRNA-146a is one of the most highly associated MicroRNA to psoriasis.
MicroRNA-146a acts as a critical physiological brake role to prevent the overactivation of inflammatory response pathways and was a key negative regulator of autoimmunity.
What does this study add?
Our data provide preliminary evidence that the rs2431697 and rs2910164 polymorphism in the microRNA-146a gene are involved in the genetic susceptibility to PsV in Southern Chinese.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
China Natural Science Foundation (No. 81301351)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the ethical committee of Affiliated Hospital of Guangdong Medical University in compliance with the Helsinki Declaration, and written informed consents were obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Any conflict of interest disclosures: The data is an original data, has not been published before and is not being considered for publication elsewhere. The authors state no conflict of interest.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- SNPs
- single nucleotide polymorphisms
- PsV
- psoriasis vulgaris
- PBMCs
- peripheral blood mononuclear cells
- NF-κB
- nuclear factor-kappaB
- IRAK1
- IL-1 receptor associated kinase 1
- TNF-α
- tumor necrosis factor-α
- IL
- interleukin
- CI
- confidence internal
- PASI
- Psoriasis Area and Severity Index.
